- Metastatic colorectal cancer and target EGFR inhibition with cetuximab2012 | Faculty of Medicine in Pilsen
- Cetuximab in metastatic mucinous adenocarcinoma of the colon +12016 | First Faculty of Medicine
- Case report: cetuximab in the 1st line of treatment of colorectal carcinoma2012 | Faculty of Medicine in Pilsen
- Using cetuximab in first-line conversion therapy for liver metastatic colorectal cancer2013 | Faculty of Medicine in Pilsen
- Cetuximab in the first line treatment of colorectal cancer2008 | First Faculty of Medicine
- Management of severe infusion reactions after cetuximab2008 | First Faculty of Medicine
- Monitoring of KRAS mutation during cetuximab treatment of head and neck squamous cell carcinoma2012 | First Faculty of Medicine
- A case study of a patient with advanced, KRAS wild-type colorectal carcinoma, treated with cetuximab2013 | Second Faculty of Medicine
- Successful management of infusion reaction accompanying the start of cetuximab therapy2007 | Publication without faculty affiliation
- Successful management of infusion reaction accompanying the start of cetuximab therapy2007 | First Faculty of Medicine
- Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab2010 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Cetuximab in the treatment of colorectal carcinoma2017 | First Faculty of Medicine
- Eye complications of cetuximab therapy2007 | Publication without faculty affiliation
- Eye complications of cetuximab therapy2007 | Faculty of Medicine in Hradec Králové
- Eye complications of cetuximab therapy2007 | First Faculty of Medicine
- The complete response rate of liver metastasis in patients with metatstatic colorectal cancer treated with the systemic chemotherapy FOLFOX and cetuximab2013 | Publication without faculty affiliation
- Cetuximab in the treatment of metastatic colorectal carcinoma - case studies2017 | First Faculty of Medicine
- Management of severe infusion reactions after cetuximab2008 | Faculty of Medicine in Hradec Králové
- Rapid, deep and long lasting respnose to cetuximab2022 | Third Faculty of Medicine
- Successful management of infusion reaction accompanying the start of cetuximab therapy2007 | Faculty of Medicine in Hradec Králové
- Comment to study: A randomized phase |III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild type (WT) KRAS metastatic colorectal cancer (mCRC) patients: German study AIO KRK-0306(FIRE-3)2013 | First Faculty of Medicine
- Skin toxicity treatment with a metastatic colorectal carcinoma patient cured with cetuximab - a clinical case report2012 | Faculty of Medicine in Pilsen
- Cetuximab and modulation EGFR - potential in therapy solid tumors2006 | First Faculty of Medicine
- Postavení cetuximabu v léčbě recidivujícího/metastazujícího spinocelulárního karcinomu hlavy a krku (R/M HNSCC)2021 | First Faculty of Medicine
- The case report of a female with oropharyngeal cancer and solitary distant metastasis, treated with a chemotherapy and cetuximab according to the EXTREME trial in combination with radiotherapy of neck region and distant metastasis2016 | Faculty of Medicine in Hradec Králové
- Experience with the administration of the combination of cetuximab with FOLFIRI in patients with metastatic colorectal cancer2013 | First Faculty of Medicine
- The role of cetuximab in the treatment of metastatic colorectal cancer2012 | Faculty of Medicine in Pilsen
- Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab2012 | Faculty of Medicine in Hradec Králové
- Cetuximab v první linii léčby metastatického kolorektálního karcinomu2016 | First Faculty of Medicine